This was shared by "NYC Purple" on the other board
Post# of 72440
Posted On: 11/22/2015 12:57:11 PM
This was shared by "NYC Purple" on the other board. It seems like Kevetrin's potential is being recognized by MD Anderson but they didn't mention it by name so can't be 100% sure.
This preclinical research shows an experimental drug currently in phase I clinical trials can replace the immunity-protecting role lost when p53 fails.
http://www.news-medical.net/news/20151121/Cru...ancer.aspx
This preclinical research shows an experimental drug currently in phase I clinical trials can replace the immunity-protecting role lost when p53 fails.
http://www.news-medical.net/news/20151121/Cru...ancer.aspx
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼